Bristol Myers Squibb shared on LinkedIn:
“Today, tumors are treated with extraordinary precision.
But treating the tumor is only part of the equation because cancer does not grow in isolation. It develops based on immune response, metabolic state, stress, inflammation and patient lifestyle.
On the latest two-part episode of DoctoRx Unscripted, Tania Small, our Head of Medical Affairs, sits down with our Board Chair and CEO Chris Boerner, Thrive Global Founder and CEO Arianna Huffington, and Neil Iyengar, Director of Survivorship Services at Winship Cancer Institute of Emory University, to explore:
- The link between gut health, metabolism and treatment success
- Emerging clinical insights on GLP-1s and body composition in oncology
- Translation of behavioral science into practical daily habits for patients
- How pharma, tech and health leaders can collaborate to make whole-person care accessible to all
Watch the full two-part episode to explore how oncology is evolving to look beyond the tumor and address the biological, behavioral and lifestyle factors that shape patient outcomes.”